Preventing heart problems in cancer patients during treatment
Primary Prevention to Reduce Cardiovascular Morbidity and Optimize Cancer Outcomes
['FUNDING_R01'] · KAISER FOUNDATION RESEARCH INSTITUTE · NIH-10880409
This study is looking to help cancer patients by figuring out who might be at risk for heart problems from their treatments and finding ways to prevent those issues, so they can stay healthy while fighting cancer.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | KAISER FOUNDATION RESEARCH INSTITUTE (nih funded) |
| Locations | 1 site (Oakland, UNITED STATES) |
| Trial ID | NIH-10880409 on ClinicalTrials.gov |
What this research studies
This research aims to identify cancer patients who are at risk of developing heart issues due to their cancer treatments and to find ways to prevent these cardiovascular problems while ensuring effective cancer care. By analyzing a large dataset that combines electronic medical records and cancer registry information, the study will evaluate the effectiveness of preventive medications in reducing heart-related complications in patients receiving potentially cardiotoxic cancer therapies. The goal is to improve both heart health and cancer treatment outcomes for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are breast cancer patients who are receiving or have received cardiotoxic cancer treatments.
Not a fit: Patients who are not undergoing cancer treatment or those with pre-existing severe cardiovascular conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better heart health and improved cancer treatment outcomes for patients undergoing therapy.
How similar studies have performed: Previous research has shown that preventive measures can be effective in reducing cardiovascular risks in high-risk populations, suggesting potential success for this approach.
Where this research is happening
Oakland, UNITED STATES
- KAISER FOUNDATION RESEARCH INSTITUTE — Oakland, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KAWATKAR, ANIKET A — KAISER FOUNDATION RESEARCH INSTITUTE
- Study coordinator: KAWATKAR, ANIKET A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Atherosclerotic Cardiovascular Disease